Patents by Inventor Stephen M. Hedrick

Stephen M. Hedrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Luminescent porous silicon nanoparticles for targeted delivery and immunization
    Patent number: 9394369
    Abstract: The disclosure relates to immunizing agents and devices.
    Type: Grant
    Filed: January 3, 2012
    Date of Patent: July 19, 2016
    Assignee: The Regents of the University of California
    Inventors: Michael J. Sailor, Stephen M. Hedrick, Lou Gu, Laura Ruff, Zhengtao Qin
  • LUMINESCENT POROUS SILICON NANOPARTICLES FOR TARGETED DELIVERY AND IMMUNIZATION
    Publication number: 20120171292
    Abstract: The disclosure relates to immunizing agents and devices.
    Type: Application
    Filed: January 3, 2012
    Publication date: July 5, 2012
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Michael J. Sailor, Stephen M. Hedrick, Lou Gu, Laura Ruff, Zhengtao Qin
  • T cell receptor beta subunit
    Patent number: 6180104
    Abstract: Oligonucleotide sequences are provided coding for T-cell-specific antigen receptors or fragments thereof. The oligonucleotide sequences can be used as probes for detecting helper and cytotoxic T-cells, preparing and isolating DNA sequences encoding for the receptor polypeptide, and in constructions for expression of receptor polypeptides or fragments thereof. In addition, processing signals from the receptor subunits can be employed in conjunction with modified wild type oligonucleotide sequences or non-wild type oligonucleotide sequences.
    Type: Grant
    Filed: May 20, 1998
    Date of Patent: January 30, 2001
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Mark M. Davis, Stephen M. Hedrick
  • T-cell receptor .beta.subunit polypeptides
    Patent number: 5840304
    Abstract: Oligonucleotide sequences are provided coding for T-cell-specific antigen receptors or fragments thereof. The oligonucleotide sequences can be used as probes for detecting helper and cytotoxic T-cells, preparing and isolating DNA sequences encoding for the receptor polypeptide, and in constructions for expression of receptor polypeptides or fragments thereof. In addition, processing signals from the receptor subunits can be employed in conjunction with modified wild type oligonucleotide sequences or non-wild type oligonucleotide sequences.
    Type: Grant
    Filed: April 29, 1994
    Date of Patent: November 24, 1998
    Assignee: Bd. of Trustees of the Leland Stanford Junior University
    Inventors: Mark M. Davis, Stephen M. Hedrick
  • T-cell receptor specific for antigen polypeptides and related polynucleotides
    Patent number: 5316925
    Abstract: Oligonucleotide sequences are provided coding for T-cell-specific antigen receptors or fragments thereof. The oligonucleotide sequences can be used as probes for detecting helper and cytotoxic T-cells, preparing and isolating DNA sequences encoding for the receptor polypeptide, and in constructions for expression of receptor polypeptides or fragments thereof. In addition, processing signals from the receptor subunits can be employed in conjunction with modified wild type oligonucleotide sequences or non-wild type oligonucleotide sequences.TM86 was deposited at the A.T.C.C. on Mar. 1, 1984 and given Accession No. 40099. TT11 was deposited at the A.T.C.C. on Oct. 22, 1984 and given Accession No. 40141.
    Type: Grant
    Filed: December 3, 1992
    Date of Patent: May 31, 1994
    Inventors: Mark M. Davis, Stephen M. Hedrick